Development migration, and survival of mast cells

被引:325
作者
Okayama, Yoshimichi
Kawakami, Toshiaki
机构
[1] La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA
[2] RIKEN, Yokohama Inst, Res Unit Allergy Transcriptome, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan
关键词
mast cell; development; proliferation; migration; survival; apoptosis; SCF; Kit; IL-3; IgE;
D O I
10.1385/IR:34:2:97
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mast cells play a pivotal role in immediate hypersensitivity and chronic allergic reactions that can contribute to asthma, atopic dermatitis, and other allergic diseases. Because mast cell numbers are increased at sites of inflammation in allergic diseases, pharmacologic intervention into the proliferation, migration, and survival (or apoptosis) of mast cells could be a promising strategy for the management of allergic diseases. Mast cells differentiate from multipotent hematopoietic progenitors in the bone marrow. Stem cell factor (SCF) is a major chemotactic factor for mast cells and their progenitors. SCF also elicits cell-cell and cell-substratum adhesion, facilitates the proliferation, and sustains the survival, differentiation, and maturation, of mast cells. Therefore, many aspects of mast cell biology can be understood as interactions of mast cells and their precursors with SCF and factors that modulate their responses to SCF and its signaling pathways. Numerous factors known to have such a capacity include cytokines that are secreted from activated T cells and other immune cells including mast cells themselves. Recent studies also demonstrated that monomeric IgE binding to Fc epsilon RI can enhance mast-cell survival. In this review we discuss the factors that regulate mast cell development, migration, and survival.
引用
收藏
页码:97 / 115
页数:19
相关论文
共 135 条
[91]  
Nishiyama C, 1999, J IMMUNOL, V163, P623
[92]   GATA-1 is required for expression of FcεRI on mast cells:: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow [J].
Nishiyama, C ;
Ito, T ;
Nishiyama, M ;
Masaki, S ;
Maeda, K ;
Nakano, N ;
Ng, W ;
Fukuyama, K ;
Yamamoto, M ;
Okumura, K ;
Ogawa, H .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (07) :847-856
[93]   Overproduction of PU.1 in mast cell progenitors: its effect on monocyte- and mast cell-specific gene expression [J].
Nishiyama, C ;
Nishiyama, M ;
Ito, T ;
Masaki, S ;
Maeda, K ;
Masuoka, N ;
Yamane, H ;
Kitamura, T ;
Ogawa, H ;
Okumura, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 313 (03) :516-521
[94]   Regulation of human FcεRI α-chain gene expression by multiple transcription factors [J].
Nishiyama, C ;
Hasegawa, M ;
Nishiyama, M ;
Takahashi, K ;
Akizawa, Y ;
Yokota, T ;
Okumura, K ;
Ogawa, H ;
Ra, C .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4546-4552
[95]   T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro [J].
Ochi, H ;
Hirani, WM ;
Yuan, Q ;
Friend, DS ;
Austen, KF ;
Boyce, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (02) :267-280
[96]   PI3K in lymphocyte development, differentiation and activation [J].
Okkenhaug, K ;
Vanhaesebroeck, B .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (04) :317-330
[97]   IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses [J].
Olivera, A ;
Urtz, N ;
Mizugishi, K ;
Yamashita, Y ;
Gilfillan, AM ;
Furumoto, Y ;
Gu, HH ;
Proia, RL ;
Baumruker, T ;
Rivera, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (05) :2515-2525
[98]   Sphingolipids and the balancing of immune cell function: Lessons from the mast cell [J].
Olivera, A ;
Rivera, J .
JOURNAL OF IMMUNOLOGY, 2005, 174 (03) :1153-1158
[99]  
Oskeritzian CA, 1999, J IMMUNOL, V163, P5105
[100]  
PEVNY L, 1995, DEVELOPMENT, V121, P163